SMTL ID : 9csg.1

Human Serum Albumin Bound to Cerastecin Compound 5e

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.91 Å

Oligo State

monomer

Ligands

6 x MYR: MYRISTIC ACID

MYR.1: 17 residues within 4Å: Chain A: Y.148, E.151, Q.194, L.217, R.220, F.221, L.236, V.239, H.240, C.243, C.251, R.255, L.258, I.262, S.285, I.288, A.289 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:Y.148, A:Q.194, A:L.236, A:V.239, A:I.262 Water bridges: A:R.220, A:R.220 Salt bridges: A:R.220 MYR.2: 16 residues within 4Å: Chain A: R.8, L.12, F.17, L.20, V.21, L.64, Y.148, P.150, L.248, L.249, A.252, R.255, A.256, L.281, L.282, S.285 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:L.12, A:L.20, A:V.21, A:L.64, A:L.249, A:A.252 Hydrogen bonds: A:L.281, A:S.285 Salt bridges: A:R.255 MYR.3: 19 residues within 4Å: Chain A: S.340, V.342, L.343, R.346, P.382, L.385, I.386, N.389, F.401, L.405, L.428, V.431, M.444, A.447, E.448, L.451, R.483, P.484 Ligands: MYR.4 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:V.342, A:L.385, A:N.389, A:F.401, A:L.451 Hydrogen bonds: A:S.340, A:S.340 Water bridges: A:R.483 Salt bridges: A:R.346, A:R.483 MYR.4: 17 residues within 4Å: Chain A: L.385, N.389, L.405, R.408, Y.409, V.413, L.421, V.424, L.428, L.451, L.455, L.458, R.483, F.486, S.487, L.489 Ligands: MYR.3 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:Y.409, A:Y.409, A:Y.409, A:Y.409, A:L.428, A:L.455, A:L.458, A:F.486, A:F.486 Hydrogen bonds: A:N.389, A:Y.409 Salt bridges: A:R.408 MYR.5: 19 residues within 4Å: Chain A: Y.399, N.403, F.500, F.505, F.507, K.523, A.526, L.527, L.530, H.533, V.545, M.546, F.549, A.550, L.573, V.574, S.577, Q.578, L.581 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:F.500, A:F.505, A:F.505, A:F.505, A:L.530, A:F.549, A:F.549, A:F.549, A:Q.578 Hydrogen bonds: A:Y.399 Salt bridges: A:K.523 MYR.6: 18 residues within 4Å: Chain A: R.207, A.208, K.210, A.211, V.214, F.226, S.230, V.233, T.234, D.322, V.323, L.325, G.326, L.329, L.345, A.348, K.349, E.352 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:K.210, A:V.214, A:V.233, A:L.325, A:L.329, A:L.345, A:A.348 Salt bridges: A:R.207

1 x 01: 2-(4-butylbenzene-1-sulfonamido)-5-(4-{3-carboxy-4-[4-(2-methoxyethyl)benzene-1-sulfonamido]anilino}-4-oxobutanamido)benzoic acid

01.7: 29 residues within 4Å: Chain A: L.113, V.114, R.115, P.116, M.121, Y.136, E.139, I.140, R.143, H.144, Y.159, L.180, L.183, R.184, D.185, K.188, A.189, S.191, A.192, R.195, E.423, N.427, K.430, V.431, K.434, Y.450, V.453, V.454, Q.457 18 PLIP interactions: 18 interactions with chain A Hydrophobic interactions: A:R.115, A:Y.136, A:I.140, A:Y.159, A:Y.159, A:R.184, A:K.188, A:K.188, A:N.427, A:V.454 Hydrogen bonds: A:H.144, A:L.180, A:K.188, A:A.192 Water bridges: A:L.113, A:L.113 Salt bridges: A:R.115, A:R.195

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Skudlarek, J.W. et al., Cerastecin Inhibition of the Lipooligosaccharide Transporter MsbA to Combat Acinetobacter baumannii : From Screening Impurity to In Vivo Efficacy. J.Med.Chem. (2024)

Release Date

2024-09-04

Peptides

Albumin: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Albumin

Related Entries With Identical Sequence